Hepatic inflammation scores correlate with common carotid intima-media thickness in rats with NAFLD induced by a high-fat diet

BMC Veterinary Research

Ying Jiang¹  Hao Zheng³  Hua Zhang²  Jing Wu³ 

[1] Department of Pathophysiology, Capital Medical University, 10 You An Men Wai Xi Tou Tiao, Beijing 100069, China;Department of Histology and Embryology, Capital Medical University, Beijing 100069, China;Department of Diagnostic Ultrasound, Xuanwu Hospital, Capital Medical University, Beijing 100053, China

关键词: Rat;    Intima-media thickness;    Ultrasound;    Atherosclerosis;    Non-alcoholic fatty liver disease;   

Others  :  870167
DOI  :  10.1186/1746-6148-10-162

 received in 2013-08-12, accepted in 2014-07-09,  发布年份 2014

【 摘 要 】

Background

Non-alcoholic fatty liver disease (NAFLD), an emerging public health problem, may be a highly atherogenic condition. But the relationship between fatty liver diseases and carotid atherosclerosis in small-animal is incompletely understood. The purpose of the present study was to evaluate carotid intima-media thickness (IMT) in NAFLD rats using high-frequency ultrasonic diagnostic equipment, and to ascertain if the degree of hepatic pathological changes was associated with carotid IMT.

Results

Liver injury was induced by a high-fat diet for 8, 12 and 16 weeks, separately, in fifty four SD rats (27 treated, 27 controls). Liver echogenicity and IMT of the carotid and aorta were evaluated and compared to histological findings of them. In comparison with the rats in the control group, fatty liver disease in rats was characterized by homogeneous and diffusely increased echogenicity (bright liver), an increased anteroposterior diameter of the liver and serum biochemical changes. Hepatic histological analyses demonstrated indications of simple steatosis in rats induced by an 8-week high-fat diet, and a high-fat diet for 12 weeks and 16 weeks could induce steatohepatitis (NASH) in rats. The 12- and 16-week groups had a significantly higher inflammation scores than those of the control groups. IMT values for the carotid and aorta were remarkably increased in the NASH groups compared with the control groups (P < 0.05). The end-diastolic velocity and systolic peak velocity of the carotid and aorta in the NASH groups were significantly smaller than those in the control group. A significant correlation between the IMT of the carotid with hepatic inflammation score (r² = 0.598, P = 0.001) and the systolic peak velocity of the carotid (r² = −0.342, P = 0.041) were shown in NAFLD rats.

Conclusion

We demonstrated that ultrasound imaging in the diagnosis of fatty liver disease and early atherosclerosis in rats is feasible and efficient, and that carotid IMT increased significantly in NASH rats but not in simple steatotic rats. A significant correlation between the IMT of the carotid artery with hepatic inflammation score were shown in NAFLD rats. This method for non-invasive diagnosis is especially relevant in the research of the pathogenesis and therapy of NAFLD and atherosclerosis using rodent models.

【 授权许可】

   
2014 Wu et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Angulo P: Nonalcoholic fatty liver disease. N Engl J Med 2002, 346:1221-1231.
• [2]Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P: The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005, 129:113-121.
• [3]Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R: Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003, 37:917-923.
• [4]Kotronen A, Yki-Järvinen H: Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008, 28:27-38.
• [5]Targher G, Arcaro G: Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007, 191:235-240.
• [6]Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, Zenari L, Cigolini M, Falezza G, Arcaro G: Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006, 29:1325-1330.
• [7]O’Leary DH, Polak JF: Intima-media thickness: a tool for atherosclerosis imaging and event prediction. Am J Cardiol 2002, 90:18-21.
• [8]Lieber CS, Leo MA, Mak KM, Xu YQ, Cao Q, Ren CL, Ponomarenko A, DeCarli LM: Model of nonalcoholic steatohepatitis. Am J Clin Nutr 2004, 79:502-509.
• [9]Koteish A, Diehl AM: Animal models of steatosis. Semin Liver Dis 2001, 21:89-104.
• [10]Nanji AA: Animal models of nonalcoholic fatty liver disease and steatohepatitis. Clin Liver Dis 2004, 8:559-574.
• [11]Daugherty A: Mouse models of atherosclerosis. Am J Med Sci 2002, 323:3-10.
• [12]Foster FS, Zhang MY, Zhou YQ, Liu G, Mehi J, Cherin E, Harasiewicz KA, Starkoski BG, Zan L, Knapik DA, Adamson SL: A new ultrasound instrument for in vivo microimaging of mice. Ultrasound Med Biol 2002, 28:1165-1172.
• [13]Wieckowska A, Feldstein AE: Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin Liver Dis 2008, 28:386-395.
• [14]Bujanda L, Hijona E, Larzabal M, Beraza M, Aldazabal P, Garcia-Urkia N, Sarasqueta C, Cosme A, Irastorza B, Gonzalez A, Arenas JI Jr: Resveratrol inhibits nonalcoholic fatty liver disease in rats. BMC Gastroenterol 2008, 8:40. BioMed Central Full Text
• [15]Liao AH, Cheng YC, Weng CH, Tsai TF, Lin WH, Yeh SH, Yeh WC, Li PC: Characterization of malignant focal liver lesions with contrast-enhanced 40 MHz ultrasound imaging in hepatitis B virus X transgenic mice: a feasibility study. Ultrason Imaging 2008, 30:203-216.
• [16]Lessa AS, Paredes BD, Dias JV, Carvalho AB, Quintanilha LF, Takiya CM, Tura BR, Rezende GFM, de Carvalho ACC, Resende CMC, Goldenberg RCS: Ultrasound imaging in an experimental model of fatty liver disease and cirrhosis in rats. BMC Vet Res 2010, 6:6. BioMed Central Full Text
• [17]Lee GP, Jeong WI, Jeong DH, Do SH, Kim TH, Jeong KS: Diagnostic evaluation of carbon tetrachloride-induced rat hepatic cirrhosis model. Anticancer Res 2005, 25:1029-1038.
• [18]Matsuhashi T, Yamada N, Shinzawa H, Takahashi T: An evaluation of hepatic ultrasound speed in injury models in rats: correlation with tissue constituents. J Ultrasound Med 1996, 15:563-570.
• [19]Layer G, Zuna I, Lorenz A, Zerban H, Haberkorn U, Bannasch P, Van Kaick G, Räth U: Computerized ultrasound B-scan texture analysis of experimental diffuse parenchymal liver disease: correlation with histopathology and tissue composition. J Clin Ultrasound 1991, 19:193-201.
• [20]McVeigh ER: Emerging imaging techniques. Circ Res 2006, 98:879-886.
• [21]Gan LM, Gronros J, Hagg U, Wikstrom J, Theodoropoulos C, Friberg P, Fritsche-Danielson R: Non-invasive real-time imaging of atherosclerosis in mice using ultrasound biomicroscopy. Atherosclerosis 2007, 190:313-320.
• [22]Palmentieri B, de Sio I, La Mura V, Masarone M, Vecchione R, Bruno S, Torella R, Persico M: The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis 2006, 38:485-489.
• [23]Jiang Y, Zhao MY, An W: Increased hepatic apoptosis in high-fat diet-induced NASH in rats may be associated with downregulation of hepatic stimulator substance. J Mol Med 2011, 89:1207-1217.
• [24]Li XM, Xia MF, Ma H, Hofman A, Hu Y, Yan HM, He WY, Lin HD, Jeekel J, Zhao NQ, Gao J, Gao X: Liver fat content is associated with increased carotid atherosclerosis in a Chinese middle-aged and elderly population: The Shanghai Changfeng study. Atherosclerosis 2012, 224:480-485.
• [25]Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR: Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999, 94:2467-2474.
• [26]Aygun C, Kocaman O, Sahin T, Uraz S, Eminler AT, Celebi A, Senturk O, Hulagu S: Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver diseas. Dig Dis Sci 2008, 53:1352-1357.
• [27]Voros K, Albert M, Vetesi F, Harmat G, Binder K, Szaniszlo F: Hepatic ultrasonographic findings in experimental carbon tetrachloride intoxication of the dog. Acta Vet Hung 1997, 45:137-150.24.
• [28]Yeager AE, Mohammed H: Accuracy of ultrasonography in the detection of severe hepatic lipidosis in cats. Am J Vet Res 1992, 53:597-599.
• [29]Nicoll RG, O’Brien RT, Jackson MW: Qualitative ultrasonography of the liver in obese cats. Vet Radiol Ultrasound 1998, 39:47-50.
• [30]Partington BP, Biller DS: Hepatic imaging with radiology and ultrasound. Vet Clin North Am Small Anim Pract 1995, 25:305-335.
• [31]Jiang Y, Zhang H, Dong LY, Wang D, An W: Increased hepatic UCP2 expression in rats with nonalcoholic steatohepatitis is associated with upregulation of Sp1 binding to its motif within the proximal promoter region. J Cell Biochem 2008, 105:277-289.
• [32]Dick R: The liver and spleen. In Textbook of radiology imaging. China: Churchill LivingstoneSutton D; 1998. 6: 981–1028
• [33]Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R: Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986, 74:1399-1406.
• [34]Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C: Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 1991, 134:250-256.
• [35]Tchelepi H, Ralls PW, Radin R, Grant E: Sonography of diffuse liver disease. J Ultrasound Med 2002, 21:1023-1032.
• [36]Razuvaev A, Lunda K, Roy J, Hedin U, Caidahl K: Noninvasive real-time imaging of intima thickness after rat carotid artery balloon injury using ultrasound biomicroscopy. Atherosclerosis 2008, 199:310-316.
• [37]Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981, 1:431-435.
• [38]Lee GS, Yan JS, Ng RK, Kakar S, Maher JJ: Polyunsaturated fat in the methionine-choline-deficient diet influences hepatic inflammation but not hepatocellular injury. J Lipid Res 2007, 48:1885-1896.
• [39]Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner C: Homeostasis model assessment: insulin resistance and beta-cell function from plasma fasting glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.